Per Rosenberg
Overview
Explore the profile of Per Rosenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radestad A, Dahm-Kahler P, Holmberg E, Bjurberg M, Hellman K, Hogberg T, et al.
Acta Obstet Gynecol Scand
. 2022 May;
101(8):923-930.
PMID: 35624547
Introduction: Minimally invasive methods to reduce menorrhagia were introduced in the 1980s and 1990s. Transcervical endometrial resection (TCRE) and endometrial ablation (EA) are two of the most frequently used methods....
2.
Marcickiewicz J, Avall-Lundqvist E, Holmberg E, Borgfeldt C, Bjurberg M, Dahm-Kahler P, et al.
Acta Oncol
. 2021 Nov;
61(1):30-37.
PMID: 34736369
Background: Poor survival rates in different cancer types are sometimes blamed on diagnostic and treatment delays, and it has been suggested that such delays might be related to sociodemographic factors...
3.
Borgfeldt C, Holmberg E, Marcickiewicz J, Stalberg K, Tholander B, Avall Lundqvist E, et al.
BMC Cancer
. 2021 Jun;
21(1):658.
PMID: 34078319
Background: The aim of this study was to analyze overall survival in endometrial cancer patients' FIGO stages I-III in relation to surgical approach; minimally invasive (MIS) or open surgery (laparotomy)....
4.
Jonsdottir B, Marcickiewicz J, Borgfeldt C, Bjurberg M, Dahm-Kahler P, Floter-Radestad A, et al.
Acta Obstet Gynecol Scand
. 2021 Mar;
100(8):1526-1533.
PMID: 33721324
Introduction: Deep myometrial invasion (≥50%) is a prognostic factor for lymph node metastases and decreased survival in endometrial cancer. There is no consensus regarding which pre/intraoperative diagnostic method should be...
5.
Dahm-Kahler P, Holmberg E, Holtenman M, Radestad A, Borgfeldt C, Hjerpe E, et al.
Gynecol Oncol
. 2021 Feb;
161(1):244-250.
PMID: 33581846
Aim: The first Swedish National Guidelines for Ovarian Cancer (NGOC) were published in 2012. We aimed to evaluate surgical outcomes and survival in patients with stage IIIC-IV disease, before and...
6.
Hellman K, Holmberg E, Bjurberg M, Borgfeldt C, Dahm-Kahler P, Radestad A, et al.
Gynecol Oncol
. 2020 Sep;
159(3):663-671.
PMID: 32988623
Objective: Vulvar cancer affects mainly elderly women and with an ageing population the incidence has increased. We explored the primary treatment patterns and relative survival of patients with vulvar squamous...
7.
Wedin M, Fredrikson M, Ahlner E, Falk A, Sandstrom A, Lindahl G, et al.
Acta Oncol
. 2019 Dec;
59(3):365-371.
PMID: 31852317
The aim of this study was to validate a translated Swedish version of the lymphoedema-specific quality of life questionnaire (LYMQOL) in a cohort of Swedish cancer patients with secondary lymphoedema...
8.
Bjurberg M, Holmberg E, Borgfeldt C, Floter-Radestad A, Dahm-Kahler P, Hjerpe E, et al.
Gynecol Oncol
. 2019 Sep;
155(2):229-236.
PMID: 31477283
Objective: Survival in cervical cancer has improved little over the last decades. We aimed to elucidate primary treatment patterns and survival. Methods: Population-based study of patients included in the Swedish...
9.
Ray-Coquard I, Cibula D, Mirza M, Reuss A, Ricci C, Colombo N, et al.
Int J Cancer
. 2019 Aug;
146(2):439-448.
PMID: 31381147
AGO-OVAR 12 investigated the effect of adding the oral triple angiokinase inhibitor nintedanib to standard front-line chemotherapy for advanced ovarian cancer. At the primary analysis, nintedanib demonstrated significantly improved progression-free...
10.
Stalberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kahler P, Floter-Radestad A, et al.
Acta Oncol
. 2019 Aug;
58(11):1628-1633.
PMID: 31373248
The aim of this study is to evaluate the impact of lymphovascular space invasion (LVSI) on the risk of lymph node metastases and survival in endometrioid endometrial adenocarcinoma. As regard...